The 53rd Annual Meeting of the EASD took place in the beautiful city of Lisbon, Portugal on 11 September 2017. The following videos are taken from the Novartis-sponsored satellite “Debating the new epoch of type 2 diabetes management: “the good, the bad and the ugly”.
Video presentations from EASD 2017 are available to view below.
Presentations taken from the Novartis-sponsored satellite “Debating the new epoch of type 2 diabetes management: “the good, the bad and the ugly”, presented at EASD 2017.
Dr Päivi Paldánius and Dr David Strain debate whether or not newly diagnosed patients with type 2 diabetes should be managed with combination therapy, presented at EASD 2017.
A number of cardiovascular outcome trials (CVOT) have been completed in recent years, but how relevant are they to practice and patients? This topic is debated by Dr Päivi Paldánius and Dr Marc Evans, presented at EASD 2017.
Should patients with heart failure and type 2 diabetes be treated with an SGLT2 inhibitor? Dr Marc Evans and Dr Mark Cooper debate the use of this class of drug in this patient population at the EASD 2017 annual meeting.
Alternatively login via
Back to epgonline.org